PA Medical News about Dementia; HMGCoA-Reductase Inhibitors

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

HMGCoA-Reductase Inhibitors in Dementia: Benefit or Harm
Clinical Medicine: Geriatrics, 07/02/09

Padala KP et al. - Dementia is a syndrome characterized by a decline in cognitive function. Alzheimer’s disease and cerebro-vascular disease are the most common causes of dementia. Many factors (genetic, life style, vascular etc.) appear to play some role in the development of dementia. Statins significantly reduce vascular disease and could reduce cognitive impairment in later life. Although most cross-sectional and longitudinal studies suggested a lower incidence of dementia in long-term statin users, randomized trials of statins in dementia did not slow disease progression. Furthermore, the effect of statins on cognitive performance is not well understood. Case reports suggest that statins may adversely affect cognition in some individuals, and prospective data studying the effects of statins in cognitively normal individuals is limited. Thus, the effects of statins on cognition in late life, remains uncertain.

<< Previous
Treatment of Obesity in Primary Care Practice in the United...

Next >>
Sources of Prescriptions for Misuse by Adolescents: Differences...

Prevalence of dementia and major dementia subtypes in Spanish populations: A reanalysis of dementia prevalence surveys, 1990-2008
BMC Neurology, 10/23/09 Relevance Score: 94%

High Prevalence of Orthostatic Hypotension in Mild Dementia
Dementia and Geriatric Cognitive Disorders, 10/15/09 Relevance Score: 93%

Predicting dementia: role of dementia risk indices
Future Neurology, 10/02/09 Relevance Score: 93%

Lipids peroxidation markers in Alzheimer's disease and vascular dementia
Geriatrics and Gerontology International, 11/17/09 Relevance Score: 91%

Promiscuous modulation of ion channels by anti-psychotic and anti-dementia medications
Medical Hypotheses, 10/05/09 Relevance Score: 91%